http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3265488-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abf04dc5bc10de6e1faad105cca3ca4f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-005 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate | 2016-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6acb46f3d97de22f9ff41c4d702b051d |
publicationDate | 2018-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-3265488-A1 |
titleOfInvention | Rkip agonism in the treatment and prevention of heart failure |
abstract | The present invention relates to a pharmaceutical composition comprising Raf kinase inhibitor protein (RKIP), or a fragment or a variant thereof; or an RKIP agonist for use in the treatment or prophylaxis of a low transvalvular pressure gradient (P mean ) in a patient. The present invention further relates to a method of treatment of a patient in need thereof, said method comprising administering to said patient a medically active amount of a compound selected from the group consisting of: a Raf kinase inhibitor protein (RKIP) or a functional fragment or a functional variant thereof; and a RKIP agonist, wherein said patient suffers from or is likely to suffer from a low transvalvular pressure gradient (P mean ). The present invention further relates to A pharmaceutical composition comprising an antagonist of CD20 and/or an anti-CD20 molecule; a VEGF antagonist; or an inhibitor of VEGF related tyrosine kinases for use in the treatment or prophylaxis of a heart failure. The present invention further relates to a corresponding method of treatment. |
priorityDate | 2015-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 895.